Rentokil Initial PLC $RTO is III Capital Management’s 6th Largest Position

III Capital Management increased its stake in shares of Rentokil Initial PLC (NYSE:RTO) by 15.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 185,132 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Rentokil Initial makes up about 0.8% of III Capital Management’s portfolio, making the stock its 6th largest position. III Capital Management’s holdings in Rentokil Initial were worth $5,454,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd boosted its position in shares of Rentokil Initial by 222.2% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,163 shares of the company’s stock valued at $34,000 after acquiring an additional 802 shares during the period. GAMMA Investing LLC boosted its position in shares of Rentokil Initial by 76.5% in the fourth quarter. GAMMA Investing LLC now owns 1,232 shares of the company’s stock valued at $36,000 after acquiring an additional 534 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Rentokil Initial in the fourth quarter valued at approximately $39,000. Smartleaf Asset Management LLC boosted its position in shares of Rentokil Initial by 171.0% in the third quarter. Smartleaf Asset Management LLC now owns 1,726 shares of the company’s stock valued at $43,000 after acquiring an additional 1,089 shares during the period. Finally, IFP Advisors Inc boosted its position in shares of Rentokil Initial by 53.8% in the third quarter. IFP Advisors Inc now owns 1,972 shares of the company’s stock valued at $50,000 after acquiring an additional 690 shares during the period. 9.91% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on RTO shares. Deutsche Bank Aktiengesellschaft lowered shares of Rentokil Initial from a “buy” rating to a “hold” rating in a research report on Tuesday, February 24th. Oppenheimer raised their price objective on shares of Rentokil Initial from $30.00 to $35.00 and gave the company an “outperform” rating in a research report on Tuesday, March 10th. UBS Group upgraded shares of Rentokil Initial from a “neutral” rating to a “buy” rating in a research report on Thursday, March 12th. Rothschild & Co Redburn upgraded shares of Rentokil Initial from a “sell” rating to a “neutral” rating in a research report on Wednesday, March 11th. Finally, Zacks Research lowered shares of Rentokil Initial from a “hold” rating to a “strong sell” rating in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, Rentokil Initial presently has a consensus rating of “Moderate Buy” and an average price target of $34.50.

Rentokil Initial Price Performance

Shares of Rentokil Initial stock opened at $29.00 on Thursday. Rentokil Initial PLC has a 1 year low of $22.72 and a 1 year high of $34.67. The company has a current ratio of 1.16, a quick ratio of 1.07 and a debt-to-equity ratio of 0.76. The company has a 50 day simple moving average of $32.10 and a two-hundred day simple moving average of $31.30.

About Rentokil Initial

Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.

Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.